CARDIAC MUSCLE--MOLECULAR MECHANISMS OF REGULATION
Project Number5R01HL045724-03
Contact PI/Project LeaderPUTKEY, JOHN ANTHONY
Awardee OrganizationUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
Description
Abstract Text
Contraction in striated muscle is regulated through a cascade of
protein-protein interactions initiated by the binding of Ca2+-to cardiac
troponin C (cTnC), the regulatory subunit of the troponin complex. The
regulatory properties of cardiac and fast skeletal muscle TnC are more
dynamic than a simple on/off molecular switch, and may be modulated by a
variety of factors including phosphorylation of other regulatory proteins
and degree of myosin crossbridges. The critical role for cTnC in muscle
contraction emphasizes a need to understand its molecular mechanism of
action. The goal of this proposal is to study structure/function
relationships in cTnC using a synergistic blend of NMR spectroscopy and
molecular biology to elucidate Ca2+-dependent protein dynamics essential
for triggering and modulating muscle contraction. The general strategy
will be to use a bacterial expression system to mutate selected amino
acids in cTnC and enrich the normal and mutated proteins with amino acids
labeled with stable isotopes to permit easy detection by NMR. This will
allow the analysis of the whole protein, and interactions between cTnC
and other regulatory proteins. A detailed understanding of
structure/function relationships in cTnC may provide insights into how
muscle contraction may be artificially modified by designing reagents
that specifically interfere with the normal function of cTnC. Moreover,
molecular mechanisms of action identified for TnC may be applicable to
other Ca2+-binding proteins with activator activity such as calmodulin.
The first Specific Aim will be to systematically mutate Met and Cys
residues and label the mutated protein with [methyl-13C]Met. Assigned
Met residues will be used as markers for conformational changes.
Mono-Cys derivatives of cTnC will be used for site-specific attachment of
fluorescent and spin-label probes. For the second Specific Aim, NMR will
be used to monitor conformational changes in labeled proteins. Protein
dynamics will be followed as a function of Ca2+ and Mg2+ binding;
association with TnI, TnT and TnI peptides; phosphorylation of TnI and
TnI peptides; and pH. The third Specific Aim will be to make sequential
assignments and define the partial solution structure of cTnC.
No Sub Projects information available for 5R01HL045724-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HL045724-03
Patents
No Patents information available for 5R01HL045724-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HL045724-03
Clinical Studies
No Clinical Studies information available for 5R01HL045724-03
News and More
Related News Releases
No news release information available for 5R01HL045724-03
History
No Historical information available for 5R01HL045724-03
Similar Projects
No Similar Projects information available for 5R01HL045724-03